|
Volumn 89, Issue 4, 2004, Pages
|
Emergence of YMDD mutant hepatitis B virus after allogeneic stem cell transplantation from a HBsAG-positive donor during lamivudine prophylaxis.
a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
HEPATITIS B SURFACE ANTIGEN;
LAMIVUDINE;
RNA DIRECTED DNA POLYMERASE INHIBITOR;
VIRUS ANTIBODY;
ALLOTRANSPLANTATION;
ARTICLE;
BLOOD;
CASE REPORT;
DISEASE TRANSMISSION;
DONOR;
GENETICS;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HEPATITIS B;
HEPATITIS B VIRUS;
HUMAN;
IMMUNOLOGY;
METHODOLOGY;
MUTATION;
PREMEDICATION;
T CELL LYMPHOMA;
ANTIBODIES, VIRAL;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HEPATITIS B;
HEPATITIS B SURFACE ANTIGENS;
HEPATITIS B VIRUS;
HUMANS;
LAMIVUDINE;
LYMPHOMA, T-CELL;
MUTATION;
PREMEDICATION;
REVERSE TRANSCRIPTASE INHIBITORS;
TISSUE DONORS;
TRANSPLANTATION, HOMOLOGOUS;
|
EID: 33644874416
PISSN: None
EISSN: 15928721
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (6)
|
References (0)
|